Archived Newsletters
-
05.12.26 -- C> CDMOs: On The Path To $75 Billion In Services?
5/12/2026
05/12/26 Outsourced Pharma Newsletter
-
05.11.26 -- STREAM Edition: Power Your Pipeline — Stream GMP, CDMO & Clinical Supply Insights
5/11/2026
05/11/26 Outsourced Pharma Newsletter
-
05.11.26 -- At INTERPHEX 2026 A Smarter Outsourcing Playbook Comes Into Focus
5/11/2026
05/11/26 Outsourced Pharma Newsletter
-
05.09.26 -- Outsourced Pharma - Best Of April
5/9/2026
05/09/26 Outsourced Pharma Newsletter
-
05.08.26 -- At INTERPHEX 2026 A Smarter Outsourcing Playbook Comes Into Focus
5/8/2026
05/08/26 Outsourced Pharma Newsletter
-
05.07.26 -- Elevating Analytical Support Across Drug Development
5/7/2026
05/07/26 Outsourced Pharma Newsletter
-
05.07.26 -- FDA Letters Made Public Are Creating New Risks
5/7/2026
05/07/26 Outsourced Pharma Newsletter
-
05.06.26 -- Are You Scaling Lyophilization Wrong?
5/6/2026
05/06/26 Outsourced Pharma Newsletter
-
05.06.26 -- FDA Letters Made Public Are Creating New Risks
5/6/2026
05/06/26 Outsourced Pharma Newsletter
-
05.05.26 -- Enabling Next-Generation Modalities Through Integrated Analytical Process Expertise
5/5/2026
05/05/26 Outsourced Pharma Newsletter